These data suggest that the timing of AURKA inhibition should be a critical factor evaluated in future studies and perhaps exclusively targeting AURKA might be insufficient at reducing tumor growth, further emphasizing the importance of targeting multiple synergistic pathways in any given tumor. Here, AURKA is linked to neoplasm.